Triumeq

Abacavir Sulfate,

Dolutegravir Sodium,

Lamivudine

4.9 Moderate risk

Triumeq & Product dose omission issue

8.7%

of users reported Product dose omission issue

62.5%

also reported Severe reaction

79.1%

are men

Most common medical consequences

Severe reaction
62.5%
Hospitalization
37.5%

Have you experienced any negative side effects from this medication?

Triumeq: general information

Most common side effects (75)

Most commonly affected ages

0 - 9 years
0.5%
10 - 19 years
0.8%
20 - 29 years
11.6%
30 - 39 years
21.8%
40 - 49 years
24.5%
50 - 59 years
26.7%
60 - 69 years
13.1%
70 - 79 years
1.1%